Loading...
Intra-Articular Syringe Condronil Ialdue Pre-Filled Hyaluronic Acid Sodium Salt 40 Mg 2 Ml Condronil
Sold out
5% off
€52,04
€54,90
Unit price
/
Unavailable
Tax included, shipping and discounts calculated at checkout.
GEOFARMA | SKU:
974003749
Notify me when it's back in stock!
Write us your email, you will be notified when this product becomes available again!
Intra-Articular Syringe Condronil Ialdue Pre-Filled Hyaluronic Acid Sodium Salt 40 Mg 2 Ml Condronil is backordered and will ship as soon as it is back in stock.
Shipping Costs and Times
Shipping Costs and Times
- Order fulfillment within 24 hours and delivery within the following 48/72 hours.
- Shipping cost: always free for orders over €49.90, otherwise it costs €4.99.
Payments
Payments
Payment information is processed securely. We do not store credit card information or have access to your credit card information.
Returns and Refunds
Returns and Refunds
You can return and receive a refund for the item within 30 days. See full policy here.
Do you need help?
Our customer service is here to help you!
- Contact us by phone, email or WhatsApp, from Monday to Friday, from 9:00 to 20:00 .
- For common questions, such as tracking your order or checking its fulfillment status, you can count on our artificial intelligence , available 24/7 .
We are always at your side to offer you fast and effective support!
Description
Description
CONDRONIL IALDUE PRE-FILLED INTRA-ARTICULAR SYRINGE HYALURONIC ACID SODIUM SALT 40 MG 2 ML CONDRONIL
CondronilIALDUE
Description
CondronilIALDUE is a sterile, biodegradable and isotonic injectable gel for intra-articular use. CondronilIALDUE consists of a medium molecular weight hyaluronic acid (1.0 – 1.5 / 106 Dalton), produced by Streptococcus equi bacteria, formulated at a concentration of 20 mg/ml in a physiological buffer.
CondronilIALDUE is characterised by viscoelastic properties, therefore it helps to normalize the viscosity of the synovial fluid present in the intra-articular cavity.
Each package contains a vial-syringe of CondronilIALDUE and an information leaflet. There are two labels showing the batch number and the expiration date. One of these labels must be applied to the patient's medical record and the other must be given to the patient to ensure traceability.
Substitute for synovial fluid which, thanks to its viscoelastic and lubricating properties, promotes the restoration of the rheological conditions of the joints, altered in the case of degenerative or post-traumatic conditions.
The product, by improving the characteristics of the synovial fluid, exerts a protective action on the joints and promotes the improvement of joint function and the reduction of painful symptoms.
CondronilIALDUE acts only at the level of the joint into which it is injected without exerting any systemic action.
Indicated for intra-articular injections only and should only be dispensed by a physician who has received specific training in the intra-articular injection technique.
How to use
Remove any joint effusion before injecting CondronilIALDUE; the same needle must be used for removing the effusion and injecting CondronilIALDUE. Remove the protective cap from the syringe, taking special care to avoid contact with the opening. Screw the 18 to 22 G diameter needle firmly onto the Luer-type locking collar following the instructions below.
Before injection, treat the site with an appropriate disinfectant.
Inject CondronilIALDUE using an aseptic technique. Inject only into the joint cavity.
It is recommended to carry out an initial cycle of three treatment sessions, at intervals of one week from each other, followed possibly by maintenance sessions, according to the medical prescription.
INSTRUCTIONS FOR ASSEMBLING THE NEEDLE ON THE SYRINGE
A. Carefully unscrew the cap from the tip of the syringe, taking special care to avoid contact with the opening.
B. Gently grasp the needle guard and fit the needle onto the Luer-lock fitting, screwing firmly until you feel a slight back pressure to ensure a watertight seal and prevent gel leakage during administration.
Components
Sodium hyaluronate (20 mg/ml), sodium chloride, sodium phosphate monobasic dihydrate, sodium phosphate dibasic dodecahydrate, water for injection
Warnings
Before use, check the integrity of the syringe and the expiry date. Do not use needles other than those indicated. The product must not be injected in the presence of an infected or severely inflamed joint. Infiltration must be avoided in case of active infections or inflammatory conditions of the skin near the site of infiltration. Since there are no clinical data available on the use of hyaluronate in children, treatment with CondronilIALDUE in these cases is not recommended. It is advisable to recommend that the patient, after the intra-articular injection, avoid physical activities that are demanding for the joint and to resume normal activities after a couple of days.
CondronilIALDUE is a single-use product, quality and sterility are guaranteed only if the syringe is sealed. Any residue must therefore be disposed of and not reused even after new sterilization.
Do not use the product if the packaging is already opened or damaged.
The syringe complete with needle must be discarded immediately after use, even if the solution has not been completely administered. After use, dispose of according to current regulations.
There are incompatibilities between sodium hyaluronate and quaternary ammonium compounds, such as benzalkonium chloride solutions. Therefore, avoid contact between CondronilIALDUE and these substances.
Some transient side effects may occur following the injection of CondronilIALDUE, such as pain, stiffness, sensation of heat, redness or swelling. These secondary manifestations can be alleviated by applying ice to the treated joint. They usually disappear after a short time. If the symptoms persist, contact a doctor. Any other unwanted side effects associated with the injection of CondronilIALDUE should be reported to your doctor.
Keep out of reach of children.
Conservation
Store CondronilIALDUE at 2-25°C (36-77°F) in a dry place in the original box. Protect from light, heat and frost.
Format
Pre-filled syringe containing 2 ml of apyrogenic gel, sterilized by moist heat.
CondronilIALDUE is a sterile, biodegradable and isotonic injectable gel for intra-articular use. CondronilIALDUE consists of a medium molecular weight hyaluronic acid (1.0 – 1.5 / 106 Dalton), produced by Streptococcus equi bacteria, formulated at a concentration of 20 mg/ml in a physiological buffer.
CondronilIALDUE is characterised by viscoelastic properties, therefore it helps to normalize the viscosity of the synovial fluid present in the intra-articular cavity.
Each package contains a vial-syringe of CondronilIALDUE and an information leaflet. There are two labels showing the batch number and the expiration date. One of these labels must be applied to the patient's medical record and the other must be given to the patient to ensure traceability.
Substitute for synovial fluid which, thanks to its viscoelastic and lubricating properties, promotes the restoration of the rheological conditions of the joints, altered in the case of degenerative or post-traumatic conditions.
The product, by improving the characteristics of the synovial fluid, exerts a protective action on the joints and promotes the improvement of joint function and the reduction of painful symptoms.
CondronilIALDUE acts only at the level of the joint into which it is injected without exerting any systemic action.
Indicated for intra-articular injections only and should only be dispensed by a physician who has received specific training in the intra-articular injection technique.
How to use
Remove any joint effusion before injecting CondronilIALDUE; the same needle must be used for removing the effusion and injecting CondronilIALDUE. Remove the protective cap from the syringe, taking special care to avoid contact with the opening. Screw the 18 to 22 G diameter needle firmly onto the Luer-type locking collar following the instructions below.
Before injection, treat the site with an appropriate disinfectant.
Inject CondronilIALDUE using an aseptic technique. Inject only into the joint cavity.
It is recommended to carry out an initial cycle of three treatment sessions, at intervals of one week from each other, followed possibly by maintenance sessions, according to the medical prescription.
INSTRUCTIONS FOR ASSEMBLING THE NEEDLE ON THE SYRINGE
A. Carefully unscrew the cap from the tip of the syringe, taking special care to avoid contact with the opening.
B. Gently grasp the needle guard and fit the needle onto the Luer-lock fitting, screwing firmly until you feel a slight back pressure to ensure a watertight seal and prevent gel leakage during administration.
Components
Sodium hyaluronate (20 mg/ml), sodium chloride, sodium phosphate monobasic dihydrate, sodium phosphate dibasic dodecahydrate, water for injection
Warnings
Before use, check the integrity of the syringe and the expiry date. Do not use needles other than those indicated. The product must not be injected in the presence of an infected or severely inflamed joint. Infiltration must be avoided in case of active infections or inflammatory conditions of the skin near the site of infiltration. Since there are no clinical data available on the use of hyaluronate in children, treatment with CondronilIALDUE in these cases is not recommended. It is advisable to recommend that the patient, after the intra-articular injection, avoid physical activities that are demanding for the joint and to resume normal activities after a couple of days.
CondronilIALDUE is a single-use product, quality and sterility are guaranteed only if the syringe is sealed. Any residue must therefore be disposed of and not reused even after new sterilization.
Do not use the product if the packaging is already opened or damaged.
The syringe complete with needle must be discarded immediately after use, even if the solution has not been completely administered. After use, dispose of according to current regulations.
There are incompatibilities between sodium hyaluronate and quaternary ammonium compounds, such as benzalkonium chloride solutions. Therefore, avoid contact between CondronilIALDUE and these substances.
Some transient side effects may occur following the injection of CondronilIALDUE, such as pain, stiffness, sensation of heat, redness or swelling. These secondary manifestations can be alleviated by applying ice to the treated joint. They usually disappear after a short time. If the symptoms persist, contact a doctor. Any other unwanted side effects associated with the injection of CondronilIALDUE should be reported to your doctor.
Keep out of reach of children.
Conservation
Store CondronilIALDUE at 2-25°C (36-77°F) in a dry place in the original box. Protect from light, heat and frost.
Format
Pre-filled syringe containing 2 ml of apyrogenic gel, sterilized by moist heat.